Case report: a thiazide diuretic to treat polyuria induced by tolvaptan

BACKGROUND: Currently, the vasopressin V2 receptor antagonist tolvaptan is the only available treatment for autosomal dominant polycystic kidney disease (ADPKD), but there are tolerability issues due to aquaretic side-effects such as polyuria. A possible strategy to ameliorate these side-effects may...

Descripción completa

Detalles Bibliográficos
Autores principales: Kramers, Bart J., van Gastel, Maatje D. A., Meijer, Esther, Gansevoort, Ron T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029076/
https://www.ncbi.nlm.nih.gov/pubmed/29970015
http://dx.doi.org/10.1186/s12882-018-0957-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029076/
https://www.ncbi.nlm.nih.gov/pubmed/29970015
http://dx.doi.org/10.1186/s12882-018-0957-7

Ejemplares similares